基金经理：邱晓旭
| 单位净值:1.0149 | 净值增长率:-7.09% | 净值增长率:-7.09% | 累计净值:1.0149 | 截止日期:2026/7/17 | |
|---|---|---|---|---|---|
| 最新估值:-(-) | 涨跌幅:- | 涨跌额:- | |||
| 最新规模:1.23亿元 | 风险等级:中高风险 | 申购状态:可申购 | 赎回状态:可赎回 |
展开全部
- 基本资料
- 投资风格
- 基金财务状况
- 基金评级
国泰创新医疗混合发起C(018160)资产配置 |
|||||
|---|---|---|---|---|---|
| 报告日期 | 股票(元) | 债券(元) | 基金总资产(元) | 基金净值(元) | 股票占净值比 |
| 2026/3/31 | 135,060,000 | 6,763,710 | 154,260,000 | 146,945,000 | 92% |
| 2025/12/31 | 19,433,700 | 1,112,270 | 21,730,300 | 20,881,800 | 93% |
| 2025/9/30 | 23,611,500 | 1,310,990 | 26,709,600 | 24,722,500 | 96% |
| 2025/6/30 | 16,181,100 | 806,099 | 17,726,800 | 17,218,000 | 94% |
| 2025/3/31 | 16,644,200 | 709,150 | 18,798,300 | 17,989,200 | 93% |
| 2024/12/31 | 13,082,400 | 712,082 | 14,233,800 | 14,070,500 | 93% |
| 2024/9/30 | 14,739,300 | 709,101 | 15,811,500 | 15,657,400 | 94% |
| 2024/6/30 | 13,798,600 | 709,465 | 14,799,900 | 14,692,400 | 94% |
| 2024/3/31 | 15,835,600 | 710,316 | 17,734,400 | 17,179,100 | 92% |
| 2023/12/31 | 23,474,100 | 807,772 | 25,390,700 | 25,057,700 | 94% |
| 2023/9/30 | 12,301,800 | 507,701 | 13,714,100 | 13,158,700 | 93% |
| 2023/6/30 | 9,929,330 | 505,596 | 11,293,300 | 11,154,800 | 89% |
*注：新浪财经提醒：以上数据由合作伙伴提供，仅供参考，交易请以正式公告数据为准。